[Provided by Toolgen. Resale and DB prohibited]
Reporter Yoo Seon-hyun = Toolgen announced on the 16th that it had signed a joint research contract with Latbio, a gene-editing animal research company, to develop a gene-editing cow that can be used in xenotransplantation fields such as artificial blood development.
The two organizations will use Toolgens CRISPR gene scissors original technology and Latbios gene-edited animal development technology to promote high value-added gene-edited animal development projects, starting with gene-editing cow-based artificial blood research.
The purpose is to reduce the possibility of infection through blood transfusions while responding to urgent blood demand.